VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The evolutionary history of post-melphalan myeloid neoplasms

Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the results of a study using whole-genome sequencing (WGS) to characterize the mechanisms of risk to developing therapy-related myeloid neoplasms in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation (autoHSCT). This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter